Barkat Health & Pharmaceutical Group: Alborz Distribution Company, a subsidiary of the Barakat Health and Pharmaceutical Group, has been recognized as a leading player in the distribution of goods and pharmaceuticals, with over 40 years of experience in the industry. This company, which is affiliated with Alborz Investment Company, is the first distribution company to be listed on the Tehran Stock Exchange.
Adhering to professional standards such as GSP (Good Storage Practices) and GDP (Good Distribution Practices), and utilizing advanced systems, Alborz Distribution Company provides fast, reliable, and 24-hour distribution services across the country through its 27 branches located in provincial capitals.
The company has recently been commended by the senior management of the Barakat Health and Pharmaceutical Holding for its remarkable growth in sales and profitability. These achievements not only reflect the company’s exceptional capabilities in distributing specialized and sensitive medicines but also highlight the ongoing efforts of its management team to enhance service quality and customer satisfaction throughout the nation.
In light of this recognition and to examine the factors behind its success, we sat down for an interview with Dr. Qais Badri, the CEO of Alborz Distribution Company. Dr. Badri, as one of the key pillars of the Barakat Health and Pharmaceutical Group in pharmaceutical distribution, shared insights into the company’s success, strategies, and plans for the year 2025. Below is the full interview.
Dr. Badri began by stating: “The work that we are seeing the results of today is expected to fully come to fruition this year. Undoubtedly, this success is the result of a truly team-oriented effort. Our dedicated colleagues have worked tirelessly in recent years, and we have always strived to show better performance each year compared to the last, regardless of the challenges and difficulties in the industry and market.”
He added: “We have a common motto within our team: ‘We strive to be better than yesterday, every day,’ and we consistently compare ourselves to our own past performance. Of course, we also acknowledge that at various points, it’s essential to keep an eye on the industry, the surrounding environment, and the competitive landscape.”
CEO of Alborz Distribution continued: “I firmly believe that the most important factor in our success is a valuable, cohesive team working across all sections of Alborz Distribution. As I have always said, from the dedicated individuals in our warehouses—who are now among the best—to those colleagues in leadership positions, including center managers, department heads, deputies, and board members—all of them have played a role in this success. This spirit of collaboration and teamwork has undoubtedly been the key to our success, and God willing, it will continue to be.”
He added: “Regarding the plans for the current year, I have repeatedly mentioned in numerous meetings that we have successfully navigated the challenging year of 2024 with firm steps and careful planning. We have reflected, thought critically, and managed to succeed under those difficult conditions. Now that we have overcome those challenges and undergone the necessary preparations, we are confident that in 2025, we will operate with even better logic and more structured planning.”
Dr. Badri concluded by stating: “I believe that 2025 will be the defining year for Alborz Distribution, both in the pharmaceutical distribution industry and within the Barakat Health and Pharmaceutical Group.”
برای امتیاز به این نوشته کلیک کنید!
